(Q36107080)

12 August 2017

1 reference

title

Sumatriptan: a decade of use and experience in the treatment of migraine (English)

1 reference

12 August 2017

2

Marcelo E Bigal

1 reference

12 August 2017

3

Stewart J Tepper

1 reference

12 August 2017

Fred D Sheftell

1

1 reference

12 August 2017

Alan M Rapoport

series ordinal

4

1 reference

12 August 2017

language of work or name

1 reference

1 March 2004

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

12 August 2017

published in

1 reference

12 August 2017

volume

4

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

199-209

1 reference

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.2.199

Ergotamine in the acute treatment of migraine: a review and European consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.2.199

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.2.199

Efficacy and tolerability of subcutaneous sumatriptan administered using the IMITREX STATdose System

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.2.199

Mixing sumatriptan: a prospective study of stratified care using multiple formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.2.199

Costs and outcomes of early versus delayed migraine treatment with sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.2.199

Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.2.199

Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.2.199

Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.2.199

Consistency of response to sumatriptan nasal spray across patient subgroups and migraine types

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.2.199

A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.2.199

Efficacy of sumatriptan nasal spray in recurrent migrainous headache: an open prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.2.199

Acute treatments: some blind alleys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.2.199

Safety of sumatriptan in pregnancy: a review of the data so far.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.2.199

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.4.2.199

21 January 2018

Identifiers

DOI

10.1586/14737175.4.2.199

1 reference

12 August 2017

1 reference